Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
672.00    -3.00 (-0.44%)
Bid:
664.00
Ask:
680.00
Spread: 16.00 (2.41%)
Market Cap: £236.81m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Director/PDMR Shareholding

21 Apr 2022 12:29

RNS Number : 9344I
B.P. Marsh & Partners PLC
21 April 2022
 

21st April 2022

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

PDMR and Director Dealings

 

B.P. Marsh (AIM: BPM), the specialist investor in early-stage financial services businesses, announces that it has been notified that Mr. Daniel Topping, Chief Investment Officer and Mr. Jonathan Newman, Group Finance Officer, have traded in the ordinary shares of 10 pence each in the Company ("Ordinary Shares").

 

The Company has been made aware that Mr. Topping on 19th April 2022 purchased 874 Ordinary Shares for 291.975p per share, or an aggregate of £2,551.86. As a result of the transaction, Daniel has a beneficial interest in 123,985 Ordinary Shares (including 11,434 shares owned by his wife Claire Cronin), together with a beneficial interest in 21,551 Ordinary Shares held in the Company's SIP Trust, representing in aggregate approximately 0.39% of the total voting rights of the Company.

 

Additionally, Daniel, as part of the Company's Joint Share Ownership Plan, has a beneficial interest (as a joint owner alongside JTC Employer Solutions Trustee) over 167,465 Ordinary Shares, representing approximately 0.45% of the total voting rights of the Company.

 

The Company has also been made aware that Mr. Newman on 19th April 2022 purchased 1,328 Ordinary Shares for 291.975p per share, or an aggregate of £3,877.43. As a result of this transaction, Jonathan has a beneficial interest in 19,645 Ordinary Shares, together with a beneficial interest in 29,671 Ordinary Shares held in the Company's SIP Trust, representing in aggregate approximately 0.13% of the total voting rights of the Company.

 

Additionally, Jonathan, as part of the Company's Joint Ownership plan, has a beneficial interest (as joint owner alongside JTC Employer Solutions Trustee) over 167,465 Ordinary Shares, representing approximately 0.45% of the total voting rights of the Company.

 

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Daniel Topping

2

Reason for notification

a)

Position / status

Chief Investment Officer, PDMR

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Purchase of Ordinary Shares via SIPP

c)

Price(s) and volumes(s)

 

Price(s)

£2.92

Volume(s)

874

d)

Aggregated information

N/A

e)

Date of the transaction

22-04-19

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jonathan Newman

2

Reason for notification

a)

Position / status

Group Finance Officer, PDMR

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Purchase of Ordinary Shares via SIPP

c)

Price(s) and volumes(s)

 

Price(s)

£2.92

Volume(s)

1328

d)

Aggregated information

N/A

e)

Date of the transaction

22-04-19

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

 

 

Nominated Adviser & Broker

Panmure Gordon (UK) Limited

Atholl Tweedie / Charles Leigh-Pemberton / Ailsa Macmaster

 

Financial PR/Investor Relations

Tavistock

Simon Hudson / Tim Pearson

+44 (0)20 7886 2500

 

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

 

Notes to Editors:

About B.P. Marsh & Partners Plc

B.P. Marsh's current portfolio contains fifteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Several of the directors have worked with each other in previous roles, and all have worked with each other for over ten years.

 

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBGDSLDDDGDB
Date   Source Headline
28th Oct 20257:00 amRNSSale of Stewart Specialty Risk Underwriting
27th Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSHalf-year Results
7th Oct 202511:15 amRNSNotice of HY Results and Investor Presentation
30th Sep 20253:52 pmRNSNew Investment: Oneglobal Broking Holdings Limited
23rd Sep 20257:00 amRNSTrading Update
22nd Sep 20253:23 pmRNSNew Investment
12th Sep 20257:00 amRNSNew Investment: Supporting the Growth of XPT Group
29th Aug 20253:54 pmRNSNew Investment - Supporting the Growth of Pantheon
22nd Aug 20252:32 pmRNSDirector/PDMR Shareholding
14th Aug 20257:00 amRNSNew Investment- supporting the growth of XPT Group
11th Aug 202512:50 pmRNSHolding(s) in Company
11th Aug 202510:35 amRNSHolding(s) in Company
11th Aug 202510:35 amRNSHolding(s) in Company
7th Aug 202512:44 pmRNSHolding(s) in Company
7th Aug 20257:05 amRNSBuyback Results, Transaction in Own Shares and TVR
7th Aug 20257:00 amRNSResult of Secondary Placing
6th Aug 20254:51 pmRNSProposed Buyback
6th Aug 20254:40 pmRNSPROPOSED SECONDARY PLACING
4th Aug 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
31st Jul 20258:05 amRNSPurchase of Own Shares and Total Voting Rights
17th Jul 202512:31 pmRNSResult of AGM
16th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
15th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
14th Jul 20252:10 pmRNSHolding(s) in Company
14th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
11th Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
3rd Jul 20254:30 pmRNSHolding(s) in Company
1st Jul 20257:00 amRNSPurchase of Own Shares and Total Voting Rights
30th Jun 20257:00 amRNSPurchase of Own Shares
30th Jun 20257:00 amRNSFollow-on equity purchase in and loan to Pantheon
24th Jun 20251:15 pmRNSNotice of AGM - correction
24th Jun 202511:39 amRNSNotice of AGM
20th Jun 202510:13 amRNSPurchase of Own Shares and Total Voting Rights
17th Jun 20257:00 amRNSNew Investment – Cameron Specialty HoldCo Limited
12th Jun 202512:30 pmRNSDirector/PDMR Shareholding
11th Jun 20254:18 pmRNSDirector/PDMR Shareholding
11th Jun 20253:33 pmRNSHolding(s) in Company
10th Jun 20254:45 pmRNSDirector/PDMR Shareholding
10th Jun 202511:30 amRNSFinal Dividend Declaration
10th Jun 20257:00 amRNSFinal Results for the Year to 31 January 2025
5th Jun 202511:15 amRNSSale of Interest in Sterling Insurance Pty Ltd
4th Jun 20252:45 pmRNSNew Investment - Amiga Speciality Holdings Limited
4th Jun 202512:23 pmRNSNotice of Annual Results and Investor Presentation
3rd Jun 202511:44 amRNSResult of Meeting
14th May 20255:34 pmRNSHolding(s) in Company
14th May 20254:53 pmRNSHolding(s) in Company
12th May 20253:17 pmRNSSecondary Share Sale
12th May 202512:15 pmRNSShare BuyBack, Notice of GM and Rule 9 Waiver
9th May 202512:49 pmRNSResult of Secondary Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.